Automated insulin delivery in older adults with type 1 diabetes
Kudva YC, Henderson RJ, Kanapka LG, et al.
NEJM Evid. 2025;4(1):EVIDoa2400200.
Leggi
AIFA: Attivazione web e pubblicazione schede di monitoraggio – PT web «Vazkepa» (icosapent etile)
16/12/2024
Leggi
The effect of automated insulin delivery system use on diabetes distress in people with type 1 diabetes and their caregivers: A systematic review and meta-analysis
Canha D, McMahon V, Schmitz S, et al.
Diabet Med. 2024:e15503.
Leggi
Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes
Shapiro MR, Tallon EM, Brown ME, et al.
Diabetologia. Pub. online 19 Dec 2024.
Leggi
AIFA: Riclassificazione del medicinale per uso umano «Vazkepa» (icosapent etile) in classe A (GU Serie Generale n.293 del 14-12-2024)
16/12/2024
Leggi
Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis
Teng Y, Fan X, Yu R, Yang X
BMC Endocr Disord. 2024;24(1):278.
Leggi
Effectiveness of semaglutide and tirzepatide in overweight and obese adults with type 1 diabetes
Snell-Bergeon JK, Kaur G, Renner D, et al.
Diabetes Technol Ther. Pub. online 2 Jan 2025.
Leggi
Predicting responsiveness to GLP-1 pathway drugs using real-world data
Zhu X, Fowler MJ, Wells QS, et al.
BMC Endocr Disord. 2024;24(1):269.
Leggi
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2-20 years) with type 1 diabetes: a population-based study
Karges B, Rosenbauer J, Stahl-Pehe A, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00284-5.
Leggi
Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
Wang Y, Lu J, Yu J, et al.
Diabetes Obes Metab. Pub. online 18 Dec 2024.
Leggi